-
Je něco špatně v tomto záznamu ?
Rhabdomyosarcoma: molecular analysis of Igf2, MyoD1 and Myogenin expression
L. Krskova, A. Augustinakova, E. Drahokoupilova, D. Sumerauer, P. Mudry, R. Kodet,
Jazyk angličtina Země Slovensko
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
21744995
DOI
10.4149/neo_2011_05_415
Knihovny.cz E-zdroje
- MeSH
- alveolární rhabdomyosarkom genetika MeSH
- dospělí MeSH
- embryonální rhabdomyosarkom genetika MeSH
- fúzní onkogenní proteiny genetika MeSH
- insulinu podobný růstový faktor II genetika MeSH
- kosterní svaly metabolismus patologie MeSH
- kostní dřeň metabolismus patologie MeSH
- lidé MeSH
- messenger RNA genetika MeSH
- míra přežití MeSH
- MyoD Protein genetika MeSH
- myogenin genetika MeSH
- nádorové biomarkery genetika MeSH
- polymerázová řetězová reakce s reverzní transkripcí MeSH
- prognóza MeSH
- transkripční faktor PAX7 genetika MeSH
- ztráta heterozygozity MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Rhabdomyosarcoma is the most common soft tissue sarcoma of childhood. There are two major histopathological types of RMS – embryonal (eRMS) and alveolar (aRMS). A molecular study of Igf2, MyoD1 and Myogenin was performed to determine the expression profiles and to assess the possible utility of these genes as potential treatment targets. Patients with RMS showed up to 100-fold increase of Igf2 transcription in comparison with normal skeletal muscle. Our data suggest that overexpression of Igf2 occurs in RMS of both histological subtypes. No correlation between the results of Igf2 mRNA expression and LOH at the 11p15 region (p= 0.12) was observed, but there was a trend of a higher expression of Igf2 mRNA in RMS samples with LOH. We observed a high level of MyoD1 mRNA in both aRMS and eRMS, and we detected a similar level of MyoD1 mRNA in RMS and normal skeletal muscles. There was a correlation between the results of MyoD1 mRNA expression and LOH at the 11p15 region.We did not observe any statistical difference in the level of Myogenin mRNA in the subgroups of RMS. Analogous to MyoD1, we observed a similar level of Myogenin mRNA in RMS and normal skeletal muscles.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12027471
- 003
- CZ-PrNML
- 005
- 20121210094323.0
- 007
- ta
- 008
- 120817s2011 xo f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.4149/neo_2011_05_415 $2 doi
- 035 __
- $a (PubMed)21744995
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xo
- 100 1_
- $a Krskova, L $u Department of Pathology and Molecular Medicine, 2nd Faculty of Medicine, Charles University and Faculty Hospital in Motol, Prague, Czech Republic. lkrskova@email.cz
- 245 10
- $a Rhabdomyosarcoma: molecular analysis of Igf2, MyoD1 and Myogenin expression / $c L. Krskova, A. Augustinakova, E. Drahokoupilova, D. Sumerauer, P. Mudry, R. Kodet,
- 520 9_
- $a Rhabdomyosarcoma is the most common soft tissue sarcoma of childhood. There are two major histopathological types of RMS – embryonal (eRMS) and alveolar (aRMS). A molecular study of Igf2, MyoD1 and Myogenin was performed to determine the expression profiles and to assess the possible utility of these genes as potential treatment targets. Patients with RMS showed up to 100-fold increase of Igf2 transcription in comparison with normal skeletal muscle. Our data suggest that overexpression of Igf2 occurs in RMS of both histological subtypes. No correlation between the results of Igf2 mRNA expression and LOH at the 11p15 region (p= 0.12) was observed, but there was a trend of a higher expression of Igf2 mRNA in RMS samples with LOH. We observed a high level of MyoD1 mRNA in both aRMS and eRMS, and we detected a similar level of MyoD1 mRNA in RMS and normal skeletal muscles. There was a correlation between the results of MyoD1 mRNA expression and LOH at the 11p15 region.We did not observe any statistical difference in the level of Myogenin mRNA in the subgroups of RMS. Analogous to MyoD1, we observed a similar level of Myogenin mRNA in RMS and normal skeletal muscles.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a kostní dřeň $x metabolismus $x patologie $7 D001853
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a insulinu podobný růstový faktor II $x genetika $7 D007335
- 650 _2
- $a ztráta heterozygozity $7 D019656
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a kosterní svaly $x metabolismus $x patologie $7 D018482
- 650 _2
- $a MyoD Protein $x genetika $7 D017570
- 650 _2
- $a myogenin $x genetika $7 D018008
- 650 _2
- $a fúzní onkogenní proteiny $x genetika $7 D015514
- 650 _2
- $a transkripční faktor PAX7 $x genetika $7 D051763
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a messenger RNA $x genetika $7 D012333
- 650 _2
- $a polymerázová řetězová reakce s reverzní transkripcí $7 D020133
- 650 _2
- $a alveolární rhabdomyosarkom $x genetika $7 D018232
- 650 _2
- $a embryonální rhabdomyosarkom $x genetika $7 D018233
- 650 _2
- $a míra přežití $7 D015996
- 650 _2
- $a nádorové biomarkery $x genetika $7 D014408
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Augustinakova, A $7 gn_A_00010061
- 700 1_
- $a Drahokoupilova, E
- 700 1_
- $a Sumerauer, D
- 700 1_
- $a Mudry, P
- 700 1_
- $a Kodet, R
- 773 0_
- $w MED00003470 $t Neoplasma $x 0028-2685 $g Roč. 58, č. 5 (2011), s. 415-23
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21744995 $y Pubmed
- 910 __
- $a ABA008 $b A 1194 $c 659 $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20121210094359 $b ABA008
- 999 __
- $a ok $b bmc $g 949513 $s 784817
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 58 $c 5 $d 415-23 $i 0028-2685 $m Neoplasma $n Neoplasma $x MED00003470
- LZP __
- $a Pubmed-20120817/11/03